4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-21-076488
10% owner sold 918,717 shares at an average $2.27 ($2,088,857)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dexcel Pharma Technologies Ltd. 10% owner | 2021-06-02 | Sale | −61,211 | $2.56 | $156,553 | 4,494,820 | D |
| Dexcel Pharma Technologies Ltd. 10% owner | 2021-06-03 | Sale | −857,506 | $2.25 | $1,932,304 | 3,637,314 | D |
| Open-market sales · 918,717 sh · avg $2.27 · $2,088,857 | |||||||
Loading xslF345X03/tm2118431-1_4seq1.xml…